The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
VectivBio Holding AG Ordinary Shares(NASDAQ:VECT) 
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for rare conditions. It develops Apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the tre...
Share this website to your friends
VectivBio Holding Ordinary Shares Days Receivable Outstanding ttm (DSO)
VectivBio Holding Ordinary Shares Op Cashflow Per Share ttm
VectivBio Holding Ordinary Shares Free Cashflow Per Share ttm
VectivBio Holding Ordinary Shares Cash Per Share ttm
VectivBio Holding Ordinary Shares P/S ratio ttm
VectivBio Holding Ordinary Shares (GAAP) P/E ratio ttm
VectivBio Holding Ordinary Shares P/B ratio ttm
No extra charts and metrics for this ticker.